Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Crystallization . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced purification method for Tedizolid Phosphate using absolute ethanol. Eliminates high-boiling solvents for superior purity and cost-effective API manufacturing.
Novel crystallization method ensures 99.9% purity for Bilastine. Reduces impurities and enhances stability for reliable pharmaceutical supply chains.
Patent CN101348463A details a robust method for Argatroban intermediates, solving moisture control issues for cost reduction in pharmaceutical manufacturing.
Discover a novel synthesis route for Mitiglinide Calcium avoiding expensive rhodium catalysts. Achieve high purity via crystalline intermediate esterification for cost-effective manufacturing.
Patent CN103980275B reveals high-purity tadalafil preparation. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN105408302B reveals advanced purification method. Enhances supply chain reliability and drives cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Patent CN120794897A details a novel salifying extraction method for Evocalcet. This process ensures high purity and cost reduction in API manufacturing for global supply chains.
Patent CN104072477B details a high-purity imatinib refining method controlling genotoxic impurities. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Optimized three-step synthesis for Capecitabine API ensures high purity and industrial scalability for global pharmaceutical supply chains and cost reduction.
Novel salt-based purification method for Rebamipide achieving >99.8% purity. Reduces impurities significantly using simple solvents. Ideal for pharmaceutical manufacturing.
Novel recrystallization method for Dienogest achieving >99% purity and >85% yield. Optimized solvent system reduces waste and enhances supply chain stability for hormonal APIs.
Patent CN115141237B reveals high-yield Rosavin Intermediate synthesis. Environmentally friendly process ensures supply chain stability and cost efficiency for global buyers.
Improved sildenafil synthesis patent CN106117212B offers high purity and cost reduction in API manufacturing for global supply chains.
Novel solvent system reduces toxic Impurity H in Ceftazidime synthesis, ensuring high purity and supply chain reliability for global pharmaceutical manufacturers.
Advanced synthesis route for Dabigatran Etexilate Mesylate avoiding high-pressure hydrogenation. Delivers high purity, low moisture, and scalable manufacturing for global supply chains.
Patent CN116925093A details a refined irinotecan synthesis using 1-methylpyrrolidine. This method offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel ethanol and THF crystallization method for Prucalopride achieving over 99.8 percent purity. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN102976980B details a water-based purification breakthrough for Probenecid, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN111377986B details a novel purification method for decitabine intermediate II, removing critical impurities to enhance beta-configuration yield and supply reliability.
Patent CN1915974A details NMP-based chiral resolution for high-purity Amlodipine. Offers significant cost reduction and supply chain reliability for API manufacturing partners.